首頁 > 市場調查報告書 > 醫療設備

生物材料

市場調查報告書

商品編碼

1626576

神經修復和再生市場：依產品、手術和地區，2024年至2031年

Nerve Repair and Regeneration Market By Product (Neurostimulation, Neuromodulation Devices, Biomaterial), Surgery (Nerve Grafting, Stem Cell Therapy) & Region for 2024-2031

出版日期: 2024年09月12日 | 出版商:

Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

神經修復與再生市場評估-2024-2031

神經損傷、神經系統疾病以及糖尿病等慢性疾病的發生率不斷上升，對有效的神經再生療法的需求也隨之增加。政府資助再生醫學研究和開發的舉措以及微創手術的廣泛使用促進了市場的擴張。此外，對個人化醫療和更特異性藥物開發的日益重視為該行業帶來了新的前景，預計到2024年將達到 88.4億美元，到2031年將達到 158.8億美元。

生物材料、幹細胞療法和 3D 列印等醫療技術的進步提高神經修復治療的成功率。此外，人口老化以及對早期介入益處的認識不斷提高也在推動市場成長，估計2024年至2031年期間的年複合成長率約為 8.37%。

神經修復與再生市場定義/概述

神經修復和再生是修復受損或受傷的神經組織並再次發揮功能的過程。神經移植、基於生物材料的支架、幹細胞療法和神經刺激用於促進癒合和再生。它用於治療週邊神經損傷、脊髓損傷、神經退化性疾病、糖尿病神經病變等。隨著基因編輯、生物電子醫學和個人化再生技術等先進治療方法的不斷研究，神經修復和再生的未來充滿希望。持續的技術進步和對神經生物學的深入了解可能會帶來突破，帶來更有效、更快捷的治療方案。

對個人化醫療的日益關注是否會推動神經修復和再生市場的發展？

隨著對個人化醫療的日益重視，神經修復和再生產業預計將大幅成長。個人化醫療根據個人的基因特徵、疾病特徵和其他生物標記制定治療方案，對神經系統疾病等複雜疾病特別有效。個人化的神經修復技術，包括基因治療、幹細胞治療和改良的生物材料，實現更有效、更個人化的治療。

2023年10月，美國國立衛生研究院（NIH）宣布未來五年增加2億美元資金，以刺激個人化神經再生技術的創意研究。此外，FDA 繼續批准針對神經系統疾病的個人化藥物，允許新藥更快上市。根據 Statista 的資料，全球個人化醫療市場預計在2023年價值達到 5,000億美元，並在2024年至2030年期間以 11.5%的年複合成長率成長。對個人化醫療的重視不僅改善了治療方法，而且還有助於擴大整個神經修復和再生產業，為患者提供更精確、更有效率、更有效的解決方案。

神經組織再生的併發症日益增多是否會阻礙神經修復和再生市場的成長？

神經組織再生的複雜性是神經修復再生領域拓展的一大障礙。神經組織，特別是中樞神經系統的神經組織很難癒合，因為成熟的神經細胞的再生能力有限。疤痕組織的形成、免疫系統反應和神經網路的複雜性都使成功治療變得困難。此外，儘管生物材料、幹細胞治療和基因編輯方面的進步顯示出巨大的前景，但將這些技術轉化為複雜損傷的實用、安全和成功的治療方法仍然是一個重大挑戰。這種複雜性意味著更長的開發時間、增加的研究成本和監管障礙，減緩整個產業的成長。

然而，神經組織再生的複雜性雖然帶來了障礙，但也刺激了該行業的創新。隨著研究的進步，人們研究 3D 列印支架、基因療法和客製化治療等新方法來解決這些障礙。此外，神經系統疾病發生率的上升，加上再生醫學資金的增加，為未來的突破創造了巨大的動力。雖然這些挑戰可能會在短期內減緩市場成長，但它們也提供了獨特的解決方案的潛力，並且從長遠來看，隨著新的、更有效的治療方法的出現，可能會加速市場的演變。

The rising prevalence of nerve injuries, neurological illnesses, and chronic diseases like diabetes is increasing the need for effective nerve regeneration treatments. Government measures to fund regenerative medicine research and development, as well as increased use of less invasive procedures, are all contributing to market expansion. Furthermore, the increased emphasis on customized medicine and the development of more specific medicines are creating new prospects in the field is fueling the USD 8.84 Billion in 2024 and reaching USD 15.88 Billion by 2031.

Advances in medical technology, such as biomaterials, stem cell therapies, and 3D printing, are improving the success of nerve repair treatments. Furthermore, increasing awareness of the benefits of early intervention, along with an aging population, is driving market growth is grow at a CAGR of about 8.37% from 2024 to 2031.

Nerve Repair and Regeneration Market: Definition/ Overview

Nerve repair and regeneration is the process of repairing damaged or injured nerve tissues so that they can function again. It uses nerve grafts, biomaterial-based scaffolds, stem cell therapy, and neurostimulation to promote healing and regeneration. Applications include the therapy of peripheral nerve injuries, spinal cord injuries, neurodegenerative disorders, and diabetic neuropathy. The future of nerve repair and regeneration looks hopeful, with continuous research into advanced therapeutics including gene editing, bioelectronic medicine, and individualized regenerative techniques. Continued technology advancements and a better understanding of neuron biology are expected to drive breakthroughs, providing promise for more effective and faster healing options.

Will Rising Focused on Personalized Medicine Propel the Nerve Repair And Regeneration Market?

The increasing emphasis on personalized therapy is expected to greatly boost the nerve repair and regeneration industry. Personalized medicine tailors therapies to individuals' genetic profiles, disease characteristics, and other biomarkers, which is especially useful for complicated ailments such as neurological disorders. Personalized techniques to nerve repair, such as gene therapies, stem cell treatments, and biomaterial modification, are enabling more effective and tailored therapies.

In October 2023, the National Institutes of Health (NIH) announced a USD 200 Million funding increase over the following five years to stimulate creative research into individualized nerve regeneration techniques. Furthermore, the FDA continues to approve tailored medicines for neurological diseases, which allows novel medications to enter the market more quickly. According to Statista, the global market for personalized medicine was valued at USD 500 Billion in 2023 and is expected to increase at an 11.5% CAGR between 2024 and 2030. As a result, the growing emphasis on customized medicine is not only improving therapeutic alternatives, but also driving the overall expansion of the nerve repair and regeneration industry, providing more accurate, efficient, and effective solutions to patients.

Will Rising Complexity of Nerve Tissue Regeneration Hinder the Growth of the Nerve Repair and Regeneration Market?

The increasing complexity of nerve tissue regeneration poses a significant obstacle to the expansion of the nerve repair and regeneration sector. Nerve tissue, particularly in the central nervous system, is naturally difficult to heal because mature neurons have limited regenerative ability. Scar tissue formation, immune system responses, and the complexity of neural networks all make successful treatment difficult. Furthermore, while advances in biomaterials, stem cell therapy, and gene editing show great promise, turning these technologies into practical, safe, and successful treatments for complicated injuries remains a significant challenge. This complexity results in longer development timeframes, greater research costs, and regulatory barriers, reducing total industry growth.

However, while the complexity of nerve tissue regeneration creates obstacles, it also stimulates industry innovation. As research progresses, novel approaches such as 3D-printed scaffolds, gene therapies, and tailored treatments are being investigated to address these obstacles. Furthermore, the rising prevalence of neurological illnesses, combined with greater funding in regenerative medicine, creates a significant incentive for future breakthroughs. While the difficulties may slow immediate market growth, they also provide potential for unique solutions, which, in the long run, may accelerate the market's evolution as new, more effective treatments become available.

Category-Wise Acumens

Will Rising Demand of Biomaterials Propel the Nerve Repair And Regeneration Market?

The biomaterials segment is expected to hold major share in the nerve repair and regeneration market, since these materials are essential for facilitating the mending of damaged nerves. Biomaterials, such as nerve conduits, scaffolds, and grafts, can help bridge nerve gaps and promote tissue regeneration, particularly in situations of peripheral nerve injury. Biomaterials have received widespread popularity as a result of advances in material science, such as the development of biocompatible, biodegradable, and synthetic choices, and their proven efficiency in nerve repair. Leading firms such as AxoGen, Inc. and Integra LifeSciences are developing biomaterial-based solutions, with AxoGen's Avance Nerve Graft being a notable example. According to a Verified Market Research the biomaterials market is predicted to exhibit a CAGR of 14.80%, driven by growing clinical uses and technological advances in nerve regeneration products.

In April 2023, The US Food and Drug Administration (FDA) approved novel biomaterial-based nerve healing devices, speeding up the clearance process and encouraging additional companies to innovate in this area. Furthermore, the European Union's Horizon 2020 initiative has provided significant financing for research into regenerative medicine and advanced biomaterials, accelerating market growth. With an increasing prevalence of nerve injuries and neurological illnesses, as well as greater investment in research and product development, demand for biomaterials is predicted to rise further, stimulating additional growth in the nerve repair and regeneration market.

However, the neurostimulation and neuromodulation devices market is the fastest expanding, driven by rising demand for non-invasive therapies for neurological illnesses and chronic pain. Technologies such as transcranial magnetic stimulation (TMS) and spinal cord stimulation (SCS) are gaining appeal as alternatives to standard surgical therapies, propelling the category forward. Neurostimulation devices are expected to rise rapidly in the next years as a result of ongoing technology innovations and increased patient awareness.

Will Rising Innovation of Nerve Grafting Fuel the Nerve Repair And Regeneration Market?

The increasing innovation in nerve grafting is expected to greatly boost the growth of the nerve repair and regeneration market, as well as upsurge its dominance over the forecast period. Nerve grafting, which uses autografts, allografts, or synthetic materials to bridge nerve gaps, has long been a staple of peripheral nerve healing. However, recent advances in nerve grafting procedures, such as the invention of bioengineered and biodegradable grafts, have resulted in better results for patients with complex nerve injuries.

In June 2023, the National Institutes of Health (NIH) announced a USD 30 Million grant to research initiatives aimed at increasing neuron regeneration through new grafting techniques such as tissue-engineered scaffolds. In March 2023, the European Commission's Horizon Europe initiative, which began, has committed funds to assist advanced biomaterial research for nerve rehabilitation, including the creation of next-generation grafts. These advancements, combined with a growing knowledge of nerve grafting's importance in treating nerve injuries, are projected to drive market growth. As new technology and techniques improve, nerve grafting will undoubtedly become more popular, making it a crucial driver of growth in the nerve repair and regeneration industry.

However, stem cell therapy is the fastest-growing component of this science. Stem cell-based treatments have the potential to significantly improve nerve regeneration by boosting tissue repair, increasing growth hormones, and minimizing scar formation. With developments in regenerative medicine and ongoing clinical trials, stem cell therapy is gaining popularity as a novel alternative to standard treatments. The expanding emphasis on regeneration techniques, combined with promising results from recent studies, is driving the rapid growth of this market, with an increasing number of hospitals and research institutions implementing stem cell therapies in nerve repair.

Country/Region-wise

Will Rising Advanced Healthcare Infrastructure in North America Drive the Nerve Repair And Regeneration Market?

The growing advanced healthcare infrastructure in North America is projected to play a significant role in driving the region's leadership in the nerve repair and regeneration market. The region has cutting-edge healthcare facilities, dynamic research and development ecosystems, and a high level of investment in medical technologies, all of which contribute to the quick acceptance of advanced nerve regeneration therapies. Companies such as Medtronic, AxoGen, and Integra LifeSciences are exploiting North America's infrastructure to launch novel nerve repair devices and therapies. Furthermore, the rising prevalence of neurological diseases, combined with a strong demand for less invasive therapies, has propelled the market's growth.

In September 2023, The United States government would contribute $50 million to advance nerve healing technology research through the National Institutes of Health (NIH). Furthermore, the FDA has accelerated the approval of numerous nerve repair treatments, including AxoGen's Avance Nerve Graft, which has become widely used in clinical settings. These efforts not only speed up the availability of novel treatments, but they also ensure that healthcare providers have access to cutting-edge technology. With rising patient demand and a favorable legislative and financial climate, North America's modern healthcare infrastructure is expected to propel significant growth in the nerve repair and regeneration market, paving the way for future innovation and accessibility.

Will Growing Awareness of Nerve Regeneration Treatments in Asia Pacific Propel the Nerve Repair and Regeneration Market?

The increasing awareness of nerve regeneration treatments in the Asia-Pacific region is projected to drive the nerve repair and regeneration market. With a rapidly developing healthcare industry, improved access to advanced medical treatments, and a growing emphasis on neurological health, there is a greater need for novel nerve repair options. As the frequency of nerve injuries, neurological illnesses such as Parkinson's disease, and diabetes-related neuropathy rises in China, India, and Japan, healthcare practitioners and patients are becoming more aware of the benefits of nerve regeneration therapy.

In September 2023, the Indian Ministry of Health and Family Welfare announced the launch of new healthcare programs aiming at boosting access to cutting-edge treatments such as nerve repair technologies. Similarly, China has made considerable investments in regenerative medicine research through its 14th Five-Year Plan (2021-2025), which includes funding for sophisticated healthcare technology such as stem cell therapies and bioengineering solutions. These government efforts, together with the growing use of minimally invasive surgical procedures and more patient awareness, are helping to drive market growth.

Competitive Landscape

The nerve repair and regeneration market is characterized by a competitive landscape driven by advancements in biomaterials, stem cell therapies, and nerve conduit technologies. Companies are increasingly focusing on developing novel solutions for peripheral nerve injuries, spinal cord regeneration, and neurological disorders. Key strategies include strategic partnerships, acquisitions, and the development of products with enhanced efficacy and minimal side effects. Additionally, emerging technologies like 3D printing, gene therapy, and neurostimulation are opening new avenues for treatment. The market is also shaped by increasing healthcare awareness, aging populations, and growing demand for minimally invasive procedures.

Some of the prominent players operating in the nerve repair and regeneration market include:

Medtronics plc

Axogen Corporation

Baxter International, Inc.

Polyganics

Integra LifeSciences

Cyberonics, Inc.

Stryker Corporation

Jude Medical, Inc.

Boston Scientific Corporation.

Latest Developments

In May 2023, Stryker Corporation acquired Wright Medical Group to extend its range of regenerative medicine and nerve repair products. The acquisition expands Stryker's expertise in tissue healing and bioengineering, establishing the business as a stronger participant in the nerve regeneration market, particularly in severe nerve injuries.

In August 2023, Integra LifeSciences revealed their innovative NeuraGen(R) 3D Nerve Conduit, which is intended to create an ideal environment for nerve regeneration. This breakthrough employs a revolutionary 3D matrix technology that promotes cell development and long-term healing, particularly in bigger nerve gaps. Integra's growth is projected to solidify its position in the peripheral nerve repair industry.

1 INTRODUCTION OF GLOBAL NERVE REPAIR AND REGENERATION MARKET

1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL NERVE REPAIR AND REGENERATION MARKET OUTLOOK

4.1 Overview
4.2 Market Dynamics
- 4.2.1 Drivers
- 4.2.2 Restraints
- 4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis

5 GLOBAL NERVE REPAIR AND REGENERATION MARKET, BY PRODUCT

5.1 Overview
5.2 Neurostimulation and Neuromodulation Devices
5.3 Biomaterial

6 GLOBAL NERVE REPAIR AND REGENERATION MARKET, BY SURGERY

6.1 Overview
6.2 Nerve Grafting
6.3 Stem Cell Therapy

7 GLOBAL NERVE REPAIR AND REGENERATION MARKET, BY GEOGRAPHY

7.1 Overview
7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
- 7.2.3 Mexico
7.3 Europe
- 7.3.1 Germany
- 7.3.2 U.K.
- 7.3.3 France
- 7.3.4 Rest of Europe
7.4 Asia Pacific
- 7.4.1 China
- 7.4.2 Japan
- 7.4.3 India
- 7.4.4 Rest of Asia Pacific
7.5 Rest of the World
- 7.5.1 Latin America
- 7.5.2 Middle East and Africa

8 GLOBAL NERVE REPAIR AND REGENERATION MARKET COMPETITIVE LANDSCAPE

8.1 Overview
8.2 Company Market Ranking
8.3 Key Development Strategies

9 COMPANY PROFILES

9.1 Medtronic's Plc
- 9.1.1 Overview
- 9.1.2 Financial Performance
- 9.1.3 Product Outlook
- 9.1.4 Key Developments
9.2 Axogen Corporation
- 9.2.1 Overview
- 9.2.2 Financial Performance
- 9.2.3 Product Outlook
- 9.2.4 Key Developments
9.3 Baxter International Inc.
- 9.3.1 Overview
- 9.3.2 Financial Performance
- 9.3.3 Product Outlook
- 9.3.4 Key Developments
9.4 Polygamic
- 9.4.1 Overview
- 9.4.2 Financial Performance
- 9.4.3 Product Outlook
- 9.4.4 Key Developments
9.5 Integra LiveScience
- 9.5.1 Overview
- 9.5.2 Financial Performance
- 9.5.3 Product Outlook
- 9.5.4 Key Developments
9.6 Cyberonics Inc.
- 9.6.1 Overview
- 9.6.2 Financial Performance
- 9.6.3 Product Outlook
- 9.6.4 Key Developments
9.7 Stryker Corporation
- 9.7.1 Overview
- 9.7.2 Financial Performance
- 9.7.3 Product Outlook
- 9.7.4 Key Developments
9.8 St. Judge Medical Inc.
- 9.8.1 Overview
- 9.8.2 Financial Performance
- 9.8.3 Product Outlook
- 9.8.4 Key Developments
9.9 Boston Scientific Corporation
- 9.9.1 Overview
- 9.9.2 Financial Performance
- 9.9.3 Product Outlook
- 9.9.4 Key Developments
9.10 Emerson Electric Company
- 9.10.1 Overview
- 9.10.2 Financial Performance
- 9.10.3 Product Outlook
- 9.10.4 Key Developments